Exploring the impact of genomics and AI on health equity and compassionate care in oncology

Clinical decision-making in hematology and oncology is increasingly driven by genomic biomarkers with research focusing on the development of diagnostic and prognostic algorithms to guide management. Ben explores the impact of genomics and artificial intelligence on equity and compassionate care in oncology. Using a large cancer database, he is examining potential disparities arising from the application of genomics and machine learning to predict clinical outcomes. He is also conducting scoping reviews of the literature to better understand how to mitigate potential disparities and integrate digital technologies into compassionate cancer care.